November 18, 2013 / 11:44 AM / 4 years ago

BRIEF-Valeant Pharma ups offering to $900 mln from $850 mln principal amount of notes

Nov 18 (Reuters) - Valeant Pharmaceuticals International Inc : * Says has priced its offering of 5.625% senior unsecured notes due 2021-SEC

filing * Valeant pharmaceuticals international inc -co increased the offering to $900

million from $850 million aggregate principal amount of notes * Source text () * Further company coverage

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below